Skip to main content
Premium Trial:

Request an Annual Quote

Cerilliant Licenses LIMS from Ocimum

NEW YORK, Dec. 16 (GenomeWeb News) - Ocimum Biosolutions has licensed its laboratory information management system, Pharmatracker, to chemical services and reference materials laboratory Cerilliant, the companies said today.


Round Rock, Tex.-based Cerilliant will use the India-based contract R&D company's LIMS to manage operations in synthesis, formulations, and quality control, said the statement.


Financial terms of the deal were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.